Pharmacy Blog

Gamma globulin effective in treating eye infections

Gamma globulin, a type of antibody isolated from blood samples that used to be routinely given to health care workers and international travelers to protect them from infectious diseases, is a highly effective treatment for pinkeye with little apparent toxicity, according to a study by researchers at the University of Pittsburgh School of Medicine.

(Continuation content ‘Gamma globulin effective in treating eye infections’…)

Men choose romance over success

Study suggests men more willing to sacrifice achievement goals for a romantic relationship.

Men may be more willing than women to sacrifice achievement goals for a romantic relationship, according to a new study by Catherine Mosher of Duke Medical Center and Sharon Danoff-Burg from the University of Albany.

(Continuation content ‘Men choose romance over success’…)

Innovative surgery for effectively treating sleep apnea

Sleep disorder and ear, nose and throat specialists at Thomas Jefferson University are examining an innovative procedure for obstructive sleep apnea syndrome treatment.

In the procedure, known as Genial Bone Advancement Trephine (GBAT), a small portion of the lower jaw which attaches to the tongue is moved forward, to pull the tongue away from the back of the airway, increasing the airway space.

(Continuation content ‘Innovative surgery for effectively treating sleep apnea’…)

HHS Secretary Reiterates Support For HIV/AIDS Efforts In Rwanda

HHS Secretary Mike Leavitt on Monday during a two-day trip to Rwanda reiterated U.S. support for HIV/AIDS and malaria efforts in the country and called for sustainable relations between the two governments, the New Times/AllAfrica.com reports (Muramila, New Times/AllAfrica.com [1], 8/27).

(Continuation content ‘HHS Secretary Reiterates Support For HIV/AIDS Efforts In Rwanda’…)

Black Family Reunions Targeted With Health, Disease Prevention Awareness Messages

Black family reunions are becoming a platform in which to promote disease prevention and healthy living, and the trend is supported by some of the nation’s leading health agencies and advocacy groups, the Washington Post reports.

(Continuation content ‘Black Family Reunions Targeted With Health, Disease Prevention Awareness Messages’…)

MS drug shows promise in 2 lethal leukemias

A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia.

The laboratory and animal study focused on the drug, called fingolimod.

(Continuation content ‘MS drug shows promise in 2 lethal leukemias’…)

Blood Banks Seeking More Hispanic Donors

Blood DonorsBlood banks across the nation are increasing their efforts to recruit Hispanic blood donors, the AP/Denver Post reports. Hispanics comprise 15% of the U.S. population, but 3% to 4% are blood donors, according to the Post.

(Continuation content ‘Blood Banks Seeking More Hispanic Donors’…)

Florida Discusses Policy Changes With Focus On Access To Care

The 500-member Florida Medical Association House of Delegates over the weekend in Hollywood, Fla., met to discuss a number of potential policy changes, with much of the focus on access to care, the Miami Herald reports.

(Continuation content ‘Florida Discusses Policy Changes With Focus On Access To Care’…)

New method of evaluating the urinary tract system reduces radiation dose

The split-bolus (cross sectional imaging) MDCT urography technique reduces both radiation dose and number of images produced, according to a recent study conducted by radiologists from Stanford University School of Medicine in Stanford, CA and VA Palo Alto Health Care System in Palo Alto, CA.

(Continuation content ‘New method of evaluating the urinary tract system reduces radiation dose’…)

Tramiprosate Phase III Clinical Trial Shows Promising Results

Neurochem announces top-line results from the North American Phase III clinical trial designed to assess the safety, efficacy and disease modification effect of tramiprosate (ALZHEMED) for the treatment of Alzheimer’s disease (AD). Following a recent meeting with the U.S.

(Continuation content ‘Tramiprosate Phase III Clinical Trial Shows Promising Results’…)